medRxiv · Aug 27, 2026

New-onset type 2 diabetes mellitus and obesity-related cancer risk: a matched cohort study (UK Biobank)

By Tipping O, Wang M, Martin R et al.

AO_SCPLOWBSTRACTC_SCPLOWO_ST_ABSBackgroundC_ST_ABSObservational research reports positive associations between type 2 diabetes mellitus (T2DM) and obesity-related cancers (ORCs), but causality remains unclear due to confounding (namely the shared risk factor of obesity, commonly approximated as body mass index, BMI), immortal time bias, and detection-time bias. Here, we aimed to use causal inference methods to minimise the above problems and estimate causal associations between new-onset T2DM and incident cancer. MethodsWe performed a cohort study within UK Biobank, comparing new-onset T2DM with unexposed individuals matched 1 to 3 on BMI, age, and sex using a sequential longitudinal approach. The primary outcomes were total incident cancer, divided into ORCs and non-obesity-related cancers (NORCs). The secondary outcomes were site-specific cancers. We developed Cox models to estimate time-split hazard ratios (tsHRs) and 95% confidence intervals (CIs) stratified by sex. Findings23,771 participants with new-onset T2DM were matched with 71,170 unexposed participants. During a median follow-up of 5 years, there were 7694 (T2DM: 2432; unexposed: 5262) incident cancers. In men, there was evidence for an effect of T2DM on obesity-related cancer (tsHR 1.39, 95% CI 1.21-1.59), particularly on hepatocellular carcinoma (tsHR 3.97, 95% CI 2.38-6.65), pancreatic (tsHR 1.77, 95% CI 1.15-2.72) and kidney (tsHR 1.62, 95% CI 1.13-2.32) cancers. In women, there was evidence for an effect on obesity-related cancers (tsHR 1.33, 95% CI 1.16-1.52). Importantly, there were no associations with post-menopausal breast and endometrial cancers, two cancer types consistently associated with elevated BMI. There was no effect of new-onset T2DM on incidence of NORCs. There was evidence of detection-time bias, particularly in men. InterpretationThis is the first large-scale study to demonstrate evidence of a BMI-independent associations between new-onset T2DM and incident cancer. In men, this was primarily driven by hepatocellular carcinoma, pancreatic cancer, and kidney cancer. In women, the underlying cancers driving this relationship were less clearly defined. FundingThis study was funded by Cancer Research UK and administered through the Manchester Cancer Research Centre MB-PhD scheme (SEBCATP-2023/100010). Novelty and impact statementThis study addresses key limitations of previous research examining T2DM and cancer risk. Unlike earlier studies that modelled T2DM as a fixed exposure and were therefore susceptible to immortal time bias, a novel longitudinal matching algorithm was implemented and treated T2DM as a time-varying exposure. In addition, extensive matching and adjustment for anthropometric measures enabled estimation of obesity-independent effects, while a time-split Cox modelling framework was used to assess and minimise detection bias and reverse causality. Research in contextO_ST_ABSEvidence before this studyC_ST_ABSWe performed a literature search relevant to the research question and identified two umbrella reviews and six meta-analyses/ systematic reviews. The studies included within the reviews were primarily based on observational evidence, except for 1 umbrella review and meta-analysis that incorporated Mendelian Randomisation (MR) evidence. The literature demonstrated an overall positive association between T2DM and cancer, however, there were discrepancies between observational and MR evidence. There were consistent associations with multiple site-specific cancers from observational evidence: pancreatic, hepatocellular, post-menopausal breast, endometrial, and colorectal, as well as inverse associations with prostate cancer. However, MR evidence illustrated a lack of consistency with observational evidence. MR studies from an umbrella review identified evidence for a causal association between T2DM and pancreatic cancer, but limited evidence for endometrial, breast, and colorectal cancer. Furthermore, it remains unclear whether the associations identified in previous observational research are causal, or due to confounding (e.g., mutual risk factor of obesity); immortal time bias (many studies combine prevalent and new-onset T2DM); time-detection bias (e.g., the co-diagnosis of two relatively common conditions at the same time); or reverse causality (liver/pancreatic cancer causing diabetes onset, but being diagnosed after the initial diabetes diagnosis). Added value of this studyOur study addressed the major issue of detection-time bias/reverse causality in previous T2DM studies by time-splitting at 1 year. Similarly, with BMI as a well-established mutual risk factor for T2DM and cancer, we performed exact matching on BMI and further adjusted for BMI as a covariate in our Cox models. We also performed sensitivity analyses, replacing BMI with alternative anthropometric measurements including waist circumference (WC), and waist-to-hip ratio (WHR). In contrast to previous studies using a never/ever categorisation for T2DM, we treated T2DM as a time-varying exposure, by adopting a sequential longitudinal matching algorithm using the date T2DM diagnosis as each participants study entry point, which helped to alleviate the effects of immortal time bias and allowed unexposed participants to develop T2DM and be subsequently followed up as an exposed participant. Implications of all the available evidenceAfter adjusting for detection-time bias, reverse causality, immortal time bias, and key confounders (BMI, smoking, deprivation, physical activity, age, sex, and alcohol consumption), our study highlighted evidence for associations between T2DM and multiple site-specific cancers, with the strongest evidence for pancreatic, liver and kidney cancers. This remained consistent with associations established in prior studies. However, we found minimal evidence for an association between T2DM, endometrial, and post-menopausal breast cancer, which has been previously reported. Overall, our study supports the notion that T2DM may be causally associated with a small number of ORCs independent of obesity. Finally, our findings highlight the significant effect of detection-time bias/reverse causality in T2DM studies, which we observed to be stronger in men, and we caution researchers to ensure they appropriately adjust for these key biases whilst trying to elucidate causal associations with T2DM as an exposure.

doi.org/10.64898/2026.08.25.26360729Open accessPopulations

AgingResearch.News